Public Policy Letters, Statements, Legal Briefs, & Other Responses

← Back to all Letters & Statements

  • ACMG Comments to CMS on Proposed NCD for Coverage of NGS for Medicare Beneficiaries with Advanced Cancer (CAG-00450N)
  • Group Sign-on Letter to Congress Supporting the Local Coverage Determination Clarification Act of 2017
  • Joint Comments to CMS Concerning MolDx Program, Medicare Coverage, and Impact on MoPath Gapfill Determinations
  • ACMG Letter to Palmetto GBA Requesting Reconsideration of Cytogenetic Microarray Coverage